Statement of Investors Complaints for the quarter ended 30th June, 2017 as required under Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015.
Titan Bio-Tech: Statement Of Investors Complaints For The Quarter Ended 30Th June,2017.
July 13, 2017
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month